{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:32:48Z","timestamp":1793503968963,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Intensiva (English Edition)"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.medine.2024.09.009","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T04:23:42Z","timestamp":1729571022000},"page":"704-713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ten take-home messages on vasopressin use in critically ill patients"],"prefix":"10.1016","volume":"48","author":[{"given":"Ricard","family":"Ferrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Lorencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josman","family":"Monclou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ochagavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Ru\u00edz-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Trenado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Villavicencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Y\u00e9benes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medine.2024.09.009_bib0005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.medin.2013.10.006","article-title":"Hemodynamic monitoring in the critically patient. Recomendations of the Cardiological Intensive Care and CPR Working Group of the Spanish Society of Intensive Care and Coronary Units","volume":"38","author":"Ochagav\u00eda","year":"2014","journal-title":"Med Intensiva"},{"key":"10.1016\/j.medine.2024.09.009_bib0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.medin.2010.10.007","article-title":"Objectives of hemodynamic resuscitation","volume":"35","author":"Mesquida","year":"2011","journal-title":"Med Intensiva"},{"key":"10.1016\/j.medine.2024.09.009_bib0015","doi-asserted-by":"crossref","first-page":"794","DOI":"10.21037\/atm.2020.04.24","article-title":"Vasopressors in septic shock: which, when, and how much?","volume":"8","author":"Shi","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jointm.2022.05.001","article-title":"Alternatives to norepinephrine in septic shock: which agents and when?","volume":"2","author":"Jozwiak","year":"2022","journal-title":"J Intensive Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00003246-199301000-00010","article-title":"Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines","volume":"21","author":"Silverman","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0030","first-page":"1","article-title":"Pathophysiology of septic shock","volume":"46 Suppl 1","author":"Chiscano-Camon","year":"2022","journal-title":"Med Intensiva (Engl Ed)"},{"key":"10.1016\/j.medine.2024.09.009_bib0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.medin.2022.03.001","article-title":"Vasoactive drugs in the treatment of septic shock","volume":"46 Suppl 1","author":"Andaluz-Ojeda","year":"2022","journal-title":"Med Intensiva (Engl Ed)"},{"key":"10.1016\/j.medine.2024.09.009_bib0040","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00134-004-2283-8","article-title":"Role of vasopressin in the management of septic shock","volume":"30","author":"Mutlu","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0040-1710320","article-title":"Vasopressor therapy in the intensive care unit","volume":"42","author":"Russell","year":"2021","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0050","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1378\/chest.120.3.989","article-title":"Physiology of vasopressin relevant to management of septic shock","volume":"120","author":"Holmes","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.medine.2024.09.009_bib0055","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ajem.2005.02.055","article-title":"Low plasma vasopressin\/norepinephrine ratio predicts septic shock","volume":"23","author":"Lin","year":"2005","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0060","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.medine.2024.09.009_bib0065","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0070","unstructured":"Centro de Informaci\u00f3n de Medicamentos, CIMA. [Accessed 1 February 2024]. Available from: https:\/\/cima.aemps.es\/cima\/pdfs\/es\/p\/83405\/P_83405.pdf."},{"key":"10.1016\/j.medine.2024.09.009_bib0075","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00134-014-3525-z","article-title":"Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine","volume":"40","author":"Cecconi","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0080","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-100-4-483","article-title":"Profound but reversible myocardial depression in patients with septic shock","volume":"100","author":"Parker","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0085","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00134-016-4503-4","article-title":"Cardiac dysfunction in sepsis","volume":"42","author":"Aneman","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0090","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00134-017-4698-z","article-title":"Left ventricular systolic dysfunction during septic shock: the role of loading conditions","volume":"43","author":"Boissier","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0095","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s00134-012-2531-2","article-title":"Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study","volume":"38","author":"Schmittinger","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcrc.2020.02.014","article-title":"Relationship between norepinephrine dose, tachycardia and outcome in septic shock: a multicentre evaluation","volume":"57","author":"Domizi","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.medine.2024.09.009_bib0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1164\/ajrccm.160.2.9810073","article-title":"Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach","volume":"160","author":"Annane","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0110","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00134-016-4249-z","article-title":"Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum","volume":"42","author":"Andreis","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF01701475","article-title":"Alterations in circulating vasoactive substances in the critically ill--a comparison between survivors and non-survivors","volume":"21","author":"Boldt","year":"1995","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s13054-016-1488-x","article-title":"Decatecholaminisation during sepsis","volume":"20","author":"Rudiger","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.medine.2024.09.009_bib0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13054-021-03495-8","article-title":"Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis","volume":"25","author":"Erstad","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.medine.2024.09.009_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2023.154258","article-title":"Refractory septic shock and alternative wordings: a systematic review of literature","volume":"75","author":"Antonucci","year":"2023","journal-title":"J Crit Care"},{"key":"10.1016\/j.medine.2024.09.009_bib0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5414\/CPP44309","article-title":"Glucocorticoid treatment in patients with septic shock: effects on vasopressor use and mortality","volume":"44","author":"Boyer","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.medine.2024.09.009_bib0140","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0145","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.medine.2024.09.009_bib0150","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/CCM.0b013e3181961ace","article-title":"Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock","volume":"37","author":"Russell","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0155","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1007\/s00134-011-2312-3","article-title":"Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: association with mortality","volume":"37","author":"Torgersen","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13054-022-04001-4","article-title":"When to start vasopressin in septic shock: the strategy we propose","volume":"26","author":"Guerci","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.medine.2024.09.009_bib0165","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","article-title":"Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock","volume":"50","author":"Sacha","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.medine.2024.09.009_bib0175","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1053\/j.jvca.2018.04.006","article-title":"Vasopressin in cardiac surgery: a meta-analysis of randomized controlled trials","volume":"32","author":"D\u00fcnser","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.medine.2024.09.009_bib0180","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1053\/j.jvca.2020.11.032","article-title":"Vasopressor therapy in cardiac surgery-an experts\u2019 consensus statement","volume":"35","author":"Guarracino","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.medine.2024.09.009_bib0185","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/ALN.0000000000000430","article-title":"Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: an in vitro study","volume":"121","author":"Currigan","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.medine.2024.09.009_bib0190","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1378\/chest.103.4.1241","article-title":"Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide","volume":"103","author":"Evora","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.medine.2024.09.009_bib0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archinternmed.2008.509","article-title":"Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest","volume":"169","author":"Mentzelopoulos","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/jama.2013.7832","article-title":"Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial","volume":"310","author":"Mentzelopoulos","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.medine.2024.09.009_bib0205","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/jama.2021.16628","article-title":"Effect of vasopressin and methylprednisolone vs placebo on return of spontaneous circulation in patients with in-hospital cardiac arrest: a randomized clinical trial","volume":"326","author":"Andersen","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.medine.2024.09.009_bib0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40560-022-00597-5","article-title":"Efficacy of combination triple therapy with vasopressin, steroid, and epinephrine in cardiac arrest: a systematic review and meta-analysis of randomized-controlled trials","volume":"10","author":"Saghafi","year":"2022","journal-title":"J Intensive Care"},{"key":"10.1016\/j.medine.2024.09.009_bib0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.resuscitation.2022.04.017","article-title":"Effect of vasopressin and methylprednisolone vs. placebo on long-term outcomes in patients with in-hospital cardiac arrest a randomized clinical trial","volume":"175","author":"Granfeldt","year":"2022","journal-title":"Resuscitation"},{"key":"10.1016\/j.medine.2024.09.009_bib0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.resuscitation.2021.02.010","article-title":"European Resuscitation Council Guidelines 2021: adult advanced life support","volume":"161","author":"Soar","year":"2021","journal-title":"Resuscitation"},{"key":"10.1016\/j.medine.2024.09.009_bib0225","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s13054-022-04255-y","article-title":"A plea for personalization of the hemodynamic management of septic shock","volume":"26","author":"De Backer","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.medine.2024.09.009_bib0230","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1164\/rccm.201905-0968OC","article-title":"Effects of a resuscitation strategy targeting peripheral perfusion status versus serum lactate levels among patients with septic shock. A Bayesian reanalysis of the ANDROMEDA-SHOCK trial","volume":"201","author":"Zampieri","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0235","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jama.2019.0071","article-title":"Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial","volume":"321","author":"Hern\u00e1ndez","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.medine.2024.09.009_bib0240","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.medin.2011.11.025","article-title":"Role of echocardiography in the hemodynamic monitorization of critical patients","volume":"36","author":"Ayuela Azcarate","year":"2012","journal-title":"Med Intensiva"},{"key":"10.1016\/j.medine.2024.09.009_bib0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/ALN.0000000000003553","article-title":"Pulse wave analysis to estimate cardiac output","volume":"134","author":"Kouz","year":"2021","journal-title":"Anesthesiology"},{"key":"10.1016\/j.medine.2024.09.009_bib0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13054-017-1739-5","article-title":"Transpulmonary thermodilution: advantages and limits","volume":"21","author":"Monnet","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.medine.2024.09.009_bib0255","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/cc4925","article-title":"Which general intensive care unit patients can benefit from placement of the pulmonary artery catheter?","volume":"10 Suppl 3","author":"Payen","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.medine.2024.09.009_bib0260","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/CCM.0000000000004617","article-title":"Fluid overload and mortality in adult critical care patients-a systematic review and meta-analysis of observational studies","volume":"48","author":"Messmer","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0265","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s00134-022-06808-9","article-title":"How can assessing hemodynamics help to assess volume status?","volume":"48","author":"De Backer","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13054-014-0732-5","article-title":"Dynamic arterial elastance predicts mean arterial pressure decrease associated with decreasing norepinephrine dosage in septic shock","volume":"19","author":"Guinot","year":"2015","journal-title":"Crit Care"},{"issue":"5 Pt. 1","key":"10.1016\/j.medine.2024.09.009_bib0275","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1152\/ajplegacy.1976.231.5.1579","article-title":"Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs","volume":"231","author":"Heyndrickx","year":"1976","journal-title":"Am J Physiol"},{"key":"10.1016\/j.medine.2024.09.009_bib0280","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/01.CCM.0000059722.94182.79","article-title":"Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors","volume":"31","author":"D\u00fcnser","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0285","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1097\/01.CCM.0000094260.05266.F4","article-title":"High-dose vasopressin is not superior to norepinephrine in septic shock","volume":"31","author":"Klinzing","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0290","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1097\/01.CCM.0000186749.34028.40","article-title":"Arginine vasopressin in 316 patients with advanced vasodilatory shock","volume":"33","author":"Luckner","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0295","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00005373-199910000-00014","article-title":"Low-dose vasopressin in the treatment of vasodilatory septic shock","volume":"47","author":"Malay","year":"1999","journal-title":"J Trauma"},{"key":"10.1016\/j.medine.2024.09.009_bib0300","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00003246-200103000-00004","article-title":"Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock","volume":"29","author":"Tsuneyoshi","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0305","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00134-003-1742-y","article-title":"Effect of vasopressin on sublingual microcirculation in a patient with distributive shock","volume":"29","author":"Dubois","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0310","doi-asserted-by":"crossref","first-page":"362.e7","DOI":"10.1016\/j.jcrc.2009.10.005","article-title":"Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study","volume":"25","author":"Bauer","year":"2010","journal-title":"J Crit Care"},{"key":"10.1016\/j.medine.2024.09.009_bib0315","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/0885066617716396","article-title":"Hemodynamic instability secondary to vasopressin withdrawal in septic shock","volume":"34","author":"Bissell","year":"2019","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.medine.2024.09.009_bib0320","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/phar.2082","article-title":"Hypotension risk based on vasoactive agent discontinuation order in patients in the recovery phase of septic shock","volume":"38","author":"Sacha","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.medine.2024.09.009_bib0325","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/phar.2265","article-title":"Effects of norepinephrine and vasopressin discontinuation order in the recovery phase of septic shock: a systematic review and individual patient data meta-analysis","volume":"39","author":"Hammond","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.medine.2024.09.009_bib0330","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.3346\/jkms.2020.35.e8","article-title":"Incidence of hypotension after discontinuation of norepinephrine or arginine vasopressin in patients with septic shock: a systematic review and meta-analysis","volume":"35","author":"Song","year":"2020","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.medine.2024.09.009_bib0335","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13054-018-2034-9","article-title":"Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)","volume":"22","author":"Jeon","year":"2018","journal-title":"Crit Care"}],"container-title":["Medicina Intensiva (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173572724002352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173572724002352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T11:59:51Z","timestamp":1732622391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173572724002352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2173572724002352"],"URL":"https:\/\/doi.org\/10.1016\/j.medine.2024.09.009","relation":{},"ISSN":["2173-5727"],"issn-type":[{"value":"2173-5727","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten take-home messages on vasopressin use in critically ill patients","name":"articletitle","label":"Article Title"},{"value":"Medicina Intensiva (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medine.2024.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.medin.2024.07.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. and SEMICYUC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}